Oppenheimer Raises Xylem (NYSE:XYL) Price Target to $147.00

Xylem (NYSE:XYLFree Report) had its price objective lifted by Oppenheimer from $142.00 to $147.00 in a report published on Friday morning, Benzinga reports. Oppenheimer currently has an outperform rating on the industrial products company’s stock.

Other analysts have also recently issued reports about the company. Robert W. Baird raised their target price on Xylem from $151.00 to $155.00 and gave the stock an outperform rating in a research note on Friday. BNP Paribas initiated coverage on Xylem in a research report on Tuesday, March 12th. They issued an outperform rating and a $150.00 price objective on the stock. Mizuho boosted their target price on Xylem from $110.00 to $135.00 and gave the company a neutral rating in a research note on Friday. Citigroup lifted their price target on shares of Xylem from $126.00 to $139.00 and gave the company a neutral rating in a report on Monday, April 8th. Finally, Stifel Nicolaus upped their price objective on shares of Xylem from $136.00 to $150.00 and gave the stock a buy rating in a report on Wednesday, February 7th. Five analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat, Xylem currently has a consensus rating of Moderate Buy and an average price target of $140.70.

Get Our Latest Analysis on Xylem

Xylem Price Performance

Shares of NYSE:XYL opened at $137.21 on Friday. The company’s fifty day moving average is $128.64 and its 200 day moving average is $115.54. The company has a quick ratio of 1.30, a current ratio of 1.67 and a debt-to-equity ratio of 0.19. Xylem has a 52 week low of $87.59 and a 52 week high of $138.46. The stock has a market cap of $33.26 billion, a PE ratio of 48.83, a PEG ratio of 2.69 and a beta of 1.08.

Xylem (NYSE:XYLGet Free Report) last announced its quarterly earnings results on Thursday, May 2nd. The industrial products company reported $0.90 EPS for the quarter, topping analysts’ consensus estimates of $0.84 by $0.06. Xylem had a return on equity of 8.95% and a net margin of 8.34%. The business had revenue of $2.03 billion for the quarter, compared to analysts’ expectations of $2 billion. During the same period in the previous year, the firm earned $0.72 EPS. The business’s quarterly revenue was up 40.4% on a year-over-year basis. Research analysts anticipate that Xylem will post 4.24 earnings per share for the current year.

Xylem Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 20th. Stockholders of record on Wednesday, February 21st were issued a dividend of $0.36 per share. The ex-dividend date of this dividend was Tuesday, February 20th. This is an increase from Xylem’s previous quarterly dividend of $0.33. This represents a $1.44 annualized dividend and a dividend yield of 1.05%. Xylem’s dividend payout ratio (DPR) is presently 51.25%.

Insider Buying and Selling

In other Xylem news, SVP Franz Cerwinka sold 2,408 shares of Xylem stock in a transaction dated Thursday, February 8th. The shares were sold at an average price of $121.79, for a total value of $293,270.32. Following the completion of the transaction, the senior vice president now directly owns 11,750 shares of the company’s stock, valued at $1,431,032.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, SVP Franz Cerwinka sold 2,408 shares of the firm’s stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total transaction of $293,270.32. Following the completion of the sale, the senior vice president now owns 11,750 shares of the company’s stock, valued at $1,431,032.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Geri-Michelle Mcshane sold 1,000 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total transaction of $122,890.00. Following the completion of the transaction, the chief accounting officer now owns 2,935 shares of the company’s stock, valued at $360,682.15. The disclosure for this sale can be found here. 0.27% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Xylem

Large investors have recently bought and sold shares of the business. Commonwealth Equity Services LLC lifted its stake in Xylem by 0.9% during the 3rd quarter. Commonwealth Equity Services LLC now owns 69,566 shares of the industrial products company’s stock valued at $6,333,000 after acquiring an additional 645 shares during the period. Cambridge Investment Research Advisors Inc. raised its holdings in shares of Xylem by 3.1% during the third quarter. Cambridge Investment Research Advisors Inc. now owns 18,603 shares of the industrial products company’s stock valued at $1,693,000 after purchasing an additional 553 shares during the last quarter. Xponance Inc. lifted its position in Xylem by 2.6% during the third quarter. Xponance Inc. now owns 36,754 shares of the industrial products company’s stock valued at $3,346,000 after purchasing an additional 938 shares during the period. Raymond James Financial Services Advisors Inc. boosted its holdings in Xylem by 21.2% in the third quarter. Raymond James Financial Services Advisors Inc. now owns 23,782 shares of the industrial products company’s stock worth $2,165,000 after purchasing an additional 4,157 shares during the last quarter. Finally, Bailard Inc. grew its position in Xylem by 8.7% in the 3rd quarter. Bailard Inc. now owns 22,371 shares of the industrial products company’s stock worth $2,036,000 after purchasing an additional 1,788 shares during the period. 87.96% of the stock is currently owned by institutional investors.

About Xylem

(Get Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Featured Stories

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.